Galectin-3 binding to β1,6 branched glycans regulate the tumor cell motility by stimulating focal adhesion modeling, FAK and PI3K activation, local F-actin instability, and α5β1 integrin translocation to fibrillar adhesions [49]. The gene discussed is PTK2; the disease is neoplasm.